Keith A. Goldan - 31 Jul 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Chief Financial Officer
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
31 Jul 2025
Net transactions value
+$10,335
Form type
4
Filing time
07 Aug 2025, 17:30:22 UTC
Previous filing
18 Jul 2025
Next filing
01 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Goldan Keith A. Chief Financial Officer 730 THIRD AVENUE, FLOOR 9, NEW YORK /s/ Michael A. Metzger, Attorney-in-Fact 07 Aug 2025 0001495411

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Other $10,335 +1,226 +1.3% $8.43 93,676 31 Jul 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,226 shares by the Reporting Person on 07/31/2025 pursuant to the Issuer's Employee Stock Purchase Plan.